1423 related articles for article (PubMed ID: 7439809)
1. Lipid metabolic studies in oophorectomized women: effects induced by two different estrogens on serum lipids and lipoproteins.
Silfverstolpe G; Gustafson A; Samsioe G; Svanborg A
Gynecol Obstet Invest; 1980; 11(3):161-9. PubMed ID: 7439809
[TBL] [Abstract][Full Text] [Related]
2. Effect of two oral contraceptives containing ethinyl estradiol and gestodene or norgestimate on different lipid and lipoprotein parameters.
Wiegratz I; Jung-Hoffmann C; Gross W; Kuhl H
Contraception; 1998 Aug; 58(2):83-91. PubMed ID: 9773262
[TBL] [Abstract][Full Text] [Related]
3. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353
[TBL] [Abstract][Full Text] [Related]
4. Comparative metabolic effects of three types of combined oral contraceptive pills in Chinese women.
Prasad RN; Liew D; Ratnam SS
Contraception; 1989 Jan; 39(1):21-35. PubMed ID: 2521321
[TBL] [Abstract][Full Text] [Related]
5. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
[TBL] [Abstract][Full Text] [Related]
6. Lipid metabolic studies in women with a polycystic ovary syndrome during treatment with a low-dose desogestrel-ethinylestradiol combination.
Cullberg G; Hamberger L; Mattsson LA; Mobacken H; Samsioe G
Acta Obstet Gynecol Scand; 1985; 64(3):203-7. PubMed ID: 3160212
[TBL] [Abstract][Full Text] [Related]
7. Oral contraceptive tablets containing 20 and 30 micrograms of ethinyl estradiol with 150 micrograms desogestrel. Their influence on lipids, lipoproteins, sex hormone binding globulin and testosterone.
Akerlund M; Almström E; Högstedt S; Nabrink M
Acta Obstet Gynecol Scand; 1994 Feb; 73(2):136-43. PubMed ID: 8116352
[TBL] [Abstract][Full Text] [Related]
8. Serum lipid and lipoprotein changes induced by new oral contraceptives containing ethinylestradiol plus levonorgestrel or desogestrel.
Gaspard UJ; Buret J; Gillain D; Romus MA; Lambotte R
Contraception; 1985 Apr; 31(4):395-408. PubMed ID: 3159546
[TBL] [Abstract][Full Text] [Related]
9. Dose and duration effects of estradiol valerate on serum and lipoprotein lipids.
Enk L; Crona N; Samsioe G; Silfverstolpe G
Horm Metab Res; 1986 Aug; 18(8):551-4. PubMed ID: 3530933
[TBL] [Abstract][Full Text] [Related]
10. The effects of two gonane progestins alone and in combination with ethinyl estradiol on serum lipoproteins.
Crona N; Silfverstolpe G; Samsioe G
Eur J Obstet Gynecol Reprod Biol; 1985 Jun; 19(6):365-74. PubMed ID: 3160616
[TBL] [Abstract][Full Text] [Related]
11. Lipid and biochemical changes after low-dose oral contraception.
Loke DF; Ng CS; Holck S; Hall PE; Ratnam SS
Contraception; 1992 Sep; 46(3):227-41. PubMed ID: 1451519
[TBL] [Abstract][Full Text] [Related]
12. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
[TBL] [Abstract][Full Text] [Related]
13. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency.
Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR
J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796
[TBL] [Abstract][Full Text] [Related]
14. Comparison of hepatic impact of oral and vaginal administration of ethinyl estradiol.
Goebelsmann U; Mashchak CA; Mishell DR
Am J Obstet Gynecol; 1985 Apr; 151(7):868-77. PubMed ID: 3920910
[TBL] [Abstract][Full Text] [Related]
15. Fasting plasma lipids, lipoproteins and apolipoproteins in Nigerian women using combined oral and progestin-only injectable contraceptives.
Oyelola OO
Contraception; 1993 May; 47(5):445-54. PubMed ID: 8513671
[TBL] [Abstract][Full Text] [Related]
16. Clinical and metabolic study of a new pill containing 20 mcg ethinylestradiol plus 0.150 mg desogestrel.
Fioretti P; Fruzzetti F; Navalesi R; Ricci C; Miccoli R; Cerri M; Orlandi MC; Melis GB
Contraception; 1987 Mar; 35(3):229-43. PubMed ID: 2956055
[TBL] [Abstract][Full Text] [Related]
17. Effects of a low-estrogen, desogestrel-containing oral contraceptive on lipid and carbohydrate metabolism.
Godsland IF; Crook D; Worthington M; Proudler AJ; Felton C; Sidhu M; Stevenson JC
Contraception; 1993 Sep; 48(3):217-27. PubMed ID: 8222652
[TBL] [Abstract][Full Text] [Related]
18. Effects of desogestrel and gestodene in low-dose oral contraceptive combinations on lipid and lipoprotein status. A randomized prospective study.
Granata A; Sobbrio GA; D'Arrigo F; Barillari M; Curasì MP; Egitto M; Trimarchi F; Granese D; Pullè C
Acta Eur Fertil; 1990; 21(3):143-6. PubMed ID: 2149913
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the effects of ethinyl estradiol and estradiol valerate on serum and lipoprotein lipids.
Lindberg UB; Enk L; Crona N; Silfverstolpe G
Maturitas; 1988 Dec; 10(4):343-52. PubMed ID: 3226339
[TBL] [Abstract][Full Text] [Related]
20. Lipid and carbohydrate metabolism studies in oophorectomized women: effects produced by the addition of norethisterone acetate to two estrogen preparations.
Silfverstolpe G; Gustafson A; Samsioe G; Svanborg A
Arch Gynecol; 1982; 231(4):279-87. PubMed ID: 7149779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
